DEBATE: Extensive stage SCLC - Thoracic Radiation? - Yes

DEBATE: Extensive stage SCLC - Thoracic Radiation? - Yes

DEBATE: Extensive stage SCLC - Thoracic Radiation? - NoПодробнее

DEBATE: Extensive stage SCLC - Thoracic Radiation? - No

Dr. Christopher Kelsey: Radiation Therapy in the Management of Small Cell Lung CancerПодробнее

Dr. Christopher Kelsey: Radiation Therapy in the Management of Small Cell Lung Cancer

What Are Your Current Practices for Consolidation Chest Radiation for Extensive SCLC?Подробнее

What Are Your Current Practices for Consolidation Chest Radiation for Extensive SCLC?

Thoracic radiotherapy in extensive stage non-small cell lung cancer improved survivalПодробнее

Thoracic radiotherapy in extensive stage non-small cell lung cancer improved survival

Debate: Surgery for stage IIIa patients with lung cancer? - YesПодробнее

Debate: Surgery for stage IIIa patients with lung cancer? - Yes

Standard-dose vs. high-dose thoracic radiotherapy in limited stage SCLCПодробнее

Standard-dose vs. high-dose thoracic radiotherapy in limited stage SCLC

Case 3: Extensive-Stage SCLCПодробнее

Case 3: Extensive-Stage SCLC

Changing the Game for ES-SCLC With Immunotherapy and Multidisciplinary CollaborationПодробнее

Changing the Game for ES-SCLC With Immunotherapy and Multidisciplinary Collaboration

Debate: Surgery versus stereotactic body radiation therapy in early stage NSCLC - SBRTПодробнее

Debate: Surgery versus stereotactic body radiation therapy in early stage NSCLC - SBRT

Palliative radiotherapy with lurbinectedin in patients with extensive stage SCLCПодробнее

Palliative radiotherapy with lurbinectedin in patients with extensive stage SCLC

Debate: Surgery versus stereotactic body radiation therapy in early stage NSCLC - SurgeryПодробнее

Debate: Surgery versus stereotactic body radiation therapy in early stage NSCLC - Surgery

ASCO Lung Cancer Roundtable - Gronberg Study - Chest Radiation with Chemo for Limited Stage SCLCПодробнее

ASCO Lung Cancer Roundtable - Gronberg Study - Chest Radiation with Chemo for Limited Stage SCLC

Debate: Should you use third-line (salvage) therapy to manage patients with advanced NSCLC? - YesПодробнее

Debate: Should you use third-line (salvage) therapy to manage patients with advanced NSCLC? - Yes

Challenges in the management of SCLCПодробнее

Challenges in the management of SCLC

Assessing the Impact of Therapeutic Advances in SCLCПодробнее

Assessing the Impact of Therapeutic Advances in SCLC

Current controversies in Small Cell Lung Cancer (SCLC)Подробнее

Current controversies in Small Cell Lung Cancer (SCLC)

Toward Better Outcomes in SCLC: Immunotherapy Has Changed the Game, but Where Do We Go Next?Подробнее

Toward Better Outcomes in SCLC: Immunotherapy Has Changed the Game, but Where Do We Go Next?